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Abstract

ANALYSIS OF NFI-X3 AND STAT3 INTERACTION AND ITS FUNCTION
By Etsegenet Tizazu, M.S.
A Thesis submitted in partial fulfillment of the requirements for the degree of Masters of
Science at Virginia Commonwealth University.

Virginia Commonwealth University, 2011

Major Director: Tomasz Kordula
Associate Professor, Department of Biochemistry and Molecular Biology

YKL-40 is a secreted protein that is highly up-regulated in malignant glioblastoma
(GBM). Its expression is correlated with the invasive nature of GBMs and poor diagnosis
of patients (Nigro et al., 2005). Previous research has shown that in astrocytes and GBM
cells, YKL-40 expression is regulated by two transcription factors, NFI-X3 and STAT3,
which form a complex with each other (Singh et al., 2011). Here, we show that the Nterminal domain of NFI-X3 is sufficient and required for its interaction with STAT3. We
also show that the DNA-binding domain of NFI-X3 is required to induce YKL-40
expression. Thus, the interaction of NFI-X3 with STAT3 may play a role in stabilizing the
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otherwise weak binding of NFI-X3 to the YKL-40 promoter. Collectively, the
observations made in this study shed light on the mechanisms by which NFI-X3, in concert
with STAT3 regulate YKL-40 expression.
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CHAPTER 1: Analysis of NFI-X3
and STAT3 interaction and its
function
Introduction
Glioblastoma:
Glioblastoma multiforme (GBM), also known as grade IV malignant glioma, is the
most common primary brain tumor. In the United States, GBM affects 13,000 people each
year (Ohgaki et al., 2005). These tumors are highly aggressive, infiltrative, and
destructive, making current treatments, such as surgical resection, radiation and
chemotherapy ineffective (Schwartzbaum et al., 2006). The average time of survival after
diagnosis is 14 months (Stupp et al., 2005). Although the molecular signaling pathways
implicated in this disease are not well understood, recent research has shown that several
signaling pathways may be involved. These pathways include phosphoinositide-3 kinase,
AKT, Ras, and mitogen-activated protein kinase (MAPK), and receptor tyrosine kinases,
including epidermal growth factor receptor (EGFR) and the vascular endothelial growth
factor receptor (VEGFR). All of these pathways contribute to the growth and promotion of
glioblastoma (Rao et al., 2004 and Guha et al., 2004). Recently, genes that are
glioblastoma targeted have been elucidated and include, Tp53 (gene encoding p53), Rb,
and PTEN. Moreover, a secreted glycoprotein, YKL-40 is overexpressed in patients with
GBM and is associated with the strong vascularized phenotype of GBM.
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YKL-40:
YKL-40, a member of the mammalian chitinase-like proteins is highly expressed in
many types of cancers, including glioblastoma. The YKL-40 gene located on chromosome
1q31-q32 is 8 kb long and consists of 10 exons (Rehli et al., 2003). It contains a single
polypeptide chain of 383 amino acids (Hakala et al., 1993). YKL-40 is named for its three
NH2-terminal amino acids Tyrosine (Y), Lysine (K) and Leucine (L) and its molecular
weight of 40 kDa. As a member of the glysosyl chitinase family 18, YKL-40 can bind to
chitin of different lengths (Aronson et al., 1997). Chitinases contain three amino acids
that are essential for their glycolytic activity: Asp, Glu and Asp. In YKL-40, the Glu
residue is replaced by Leu and as a result, YKL-40 does not have chitinase activity
(Renkema et al., 1998). YKL-40 contains two possible sites of glycosylation, but only the
NH2-terminal is glycosylated with two units of N-acetylglucosamine via β(1-4) linkage. It
contains a binding site for heparin and two binding sites for hyaluronan acid (Fusetti et al.,
2003).
Many cells secrete YKL-40, including macrophages, chondrocytes and synovial
cells (Krause et al., 1996, Hakala et al., 1993). YKL-40 is a growth factor for fibroblasts,
synovial cells and chondrocytes (De Ceuninck et al., 2001, Recklies et al., 2002, Ling et
al., 2004). In fibroblasts, YKL-40 initiates mitogen-activated protein kinase and PI-3kinase signaling cascades leading to the phosphorylation of both ERK 1/2 and protein
kinase B (AKT) (Recklies et al., 2002 and Ling et al., 2004). As this signaling cascade is
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associated with the control of mitogenesis, it is indicative of a role of YKL-40 as an antiapoptotic protein.
YKL-40 is one of the most highly expressed genes in GBM and is secreted in vitro
by human glioma cell lines (Nigro et al., 2005). Even though its role in cancer is not yet
fully understood, it is believed that YKL-40 may play a role in the proliferation and
differentiation of malignant cells, protection of cancer cells from undergoing apoptosis,
stimulating angiogenesis and tissue remodeling. In immortalized astrocytes, YKL-40
increases resistance to radiation and increased invasion in vitro (Nigro et al., 2005). YKL40 also plays a role in angiogenesis by stimulating the migration and re-organization of
vascular endothelial cells (Malinda et al., 1999). Recently, it was shown that YKL-40 can
act as an independent angiogenic factor and can also up-regulate VEGF, resulting in a
synergistic effect on angiogenesis.

In addition, YKL-40- induced angiogenesis is

dependent on the interaction between membrane receptors syndecan-1 (Syn-1) and integrin
αvβ3 (Francescone et al., 2011).
Moreover, mice lacking YKL-40 gene have impaired antigen induced Th2
responses with YKL-40 acting as a potent inhibitor of death-receptor induced
inflammatory cell apoptosis. The expression of IL-4 and IL-13 was decreased in YKL-40
null animals challenged with antigen compared to sham treated animals (Lee et al., 2009).
Even though YKL-40 has recently received much attention as a diagnostic marker
for many diseases, little is known about its regulation. The YKL-40 promoter contains
binding sites for many transcription factors, including: PU.1, Sp1, Sp3, USF, AML-1 and
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C/EBP (Rehli et al., 2003). Also, NF-κB, specifically its p65 and p50 subunits, negatively
regulates YKL-40 in glioma cells (Bhat et al., 2008). Furthermore, YKL-40 expression in
the brain is regulated by Nuclear Factor I-X (NFI-X) and Signal Transducers and
Activators of Transcription 3 (STAT3) (Singh et al., 2011).

Signal Transducers and Activators of Transcription (STAT):
Signal Transducers and Activators of Transcription proteins regulate many aspects
of growth, survival and differentiation in cells. In the human genome, STATs are clustered
on three chromosomes and consist of seven mammalian members (STAT1, 2, 3, 4, 5a, 5b
and 6). STAT proteins are between 700-850 amino acids long and contain many
functional domains. They consist of an N-terminal protein interaction domain, coiled-coil
domain, DNA binding domain, linker domain, SH2 domain and transactivation domain.
At the C-terminus, all STATs contain a conserved Tyr residue that upon phosphorylation,
interacts with the SH2 domain and allows their dimerization. Most STATs, excluding
STAT2 and STAT6, contain a second conserved Ser residue at the transactivation domain
that can be phosphorylated. The N-terminus of STATs is involved in dimerization,
tetramerization and protein-protein interactions (Vinkemier et al., 1998). The coiled-coil
domain is involved in the interaction with other proteins and may play a role in receptor
binding (Zhang et al., 2000). The DNA binding domain assumes an immunoglobulin-fold
structure and is involved in nuclear translocation by maintaining proper conformation for
importin binding (Ma et al., 2006). The linker domain is involved in transcriptional
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activation (Yang et al., 1999) and protein-protein interaction (Lufei et al., 2003). The SH2
domain, the most conserved domain, is critical for receptor association and phospho-dimer
formation. The least conserved transactivation domain is involved in protein-protein
interaction with CBP (p300)-binding protein and many other proteins, which leads to the
specific activation of transcription (Zhang et al., 1996). STAT1 and STAT2 dimerize and
can form a complex with IRF9 to bind the Interferon Sensitive Response Element (ISRE),
while all other STATs bind to the Gamma interferon Activation Site (GAS) element.
STATs are activated by many cytokines, growth factors and hormones. STAT1
activation is induced by IFN-α/β/γ. STAT1 is involved in anti-viral and anti-bacterial
response, growth inhibition, apoptosis and tumor suppression. STAT2 is involved in IFN
response. STAT3 is activated by cytokines and growth factors, such as IL-6 family
members and EGF. STAT3 functions in wound-healing, regeneration of liver, mammary
involution and survival of many cell types and is the only STAT that is required for early
development (Takeda et al., 1997, Akira, 2000 and Poli et al., 2003). It is involved in
survival, anti-apoptosis, mitogenesis and oncogenesis (Bromberg, 2001). STAT4 is
induced by IL-12 and is involved in Th1 development, whereas STAT6 is involved in Th2
development and is activated by IL-4. STAT5a is involved in prolactin hormone signaling
and STAT5b is involved in growth hormone signaling.
Upon activation, STATs are Tyrosine phosphorylated, which is important for their
dimerization, nuclear import, DNA binding and transcriptional activation. This activation
can take place by many mechanisms. Binding of cytokines leads to dimerization of the
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cytokine receptors, which then leads to activation of the receptor-associated tyrosine
kinase, Janus Kinases (JAKs). JAKs then trans-phosphorylate Tyr residues in the
intracellular domain of the receptor. The phosphorylated Tyrosines provide a binding
scaffold for STATs, which are recruited to the receptor via their SH2 domains. JAKs then
phosphorylate STATs on a specific Tyr residue on the cytoplasmic tail, allowing them to
form homo- or hetero- dimers by reciprocal binding of the phospho-Tyr to the SH2 domain
of the partner. Upon dimerization, STATs dissociate from the receptor, translocate to the
nucleus by associating with importins, bind DNA and activate the transcription of
cytokine-responsive genes. Another mode of activation is with receptors that have
intrinsic tyrosine kinase activities, which activate STATs directly. Yet another mechanism
is via non-receptor tyrosine kinases, often used by viral oncoproteins that lead to
constitutive activation of STATs.
Inactivation of STATs is regulated by many mechanisms, including the cytokineinducible SH2-containing protein (CIS), suppressor of cytokine signaling (SOCS), STAT
inhibitor (SSI), protein inhibitor of activated STAT (PIAS) and phosphatases as well as the
ubiquitin-proteosome pathway (Kim, 1996). The family of SOCS/CIS proteins suppresses
cytokine signaling by several mechanisms including competition for phosphor-Tyr binding
and promoting degradation of signaling molecules via ubiquitination (Starr et al., 2003),
whereas the PIAS family interact directly with phosphorylated STATs in the nucleus and
block their binding to DNA.
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STATs play a central role in determining immune responses in cytokine-dependent
inflammation and immunity. These proteins may control whether immune responses in the
tumor environment promote or inhibit cancer. While STAT1, STAT5 and STAT6 are
involved in inhibiting anti-tumor immunity, STAT3 regulates genes that are involved in
tumor proliferation, survival, angiogenesis and invasion (Yu et al., 2007). STAT3
activation promotes tumor growth by antagonizing NF-κB and STAT1-mediated antitumor response and mediating T regulatory cell expansion and TH17 development (Wang
et al., 2009; Wu et al., 2009). STAT3 induces the expression of cytokines and
chemokines, such as COX2 and IL-6 that are associated with cancer-promoting
inflammation. Thus, STAT3 forms an autocrine and paracrine feed- forward loop that
results in promotion of cancer. Additionally, STAT3 is constitutively activated in almost
all human glioblastoma multiforme tissue. Furthermore, GBMs have higher expression
levels of IL-6 and OSM, leading to constant activation of STAT3 signaling (Lim and Cao,
2006).
Nuclear Factor I (NFI):
The Nuclear Factor I family of transcription factors constitutes of four DNAbinding proteins, NFI-A, NFI-B, NFI-C, and NFI-X, which regulate the transcription of
many cellular and viral genes as well as viral DNA replication. They are encoded by four
highly conserved genes: Nfia, Nfib, Nfic, and Nfix. NFI proteins form homo- and heterodimers to bind the consensus sequence TTGGC(N)5GCCAA on duplex DNA
(Henninghausen et al., 1985, Leegwater et al., 1985, and Nowock et al., 1985).
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In vertebrates, the four NFI genes are alternatively spliced yielding multiple mRNA
and proteins from each gene. However, all isoforms of NFIs contain a conserved Nterminal DNA-binding and dimerization domain. The DNA-binding and dimerization
domain is 200 amino acids long and is highly conserved within the four genes. This
domain is enough for DNA-binding, dimerization and stimulation of adenoviral DNA
replication (Mermod et al., 1989, Gounari et al., 1990) and is preceded by exons encoding
8-47 amino acid domain of unknown function, but is strongly conserved between the four
genes (Meisterernst et al., 1989). Point mutations made in this region have shown that
dimerization is needed for DNA-binding activity; however, DNA-binding ability can be
eliminated independently of dimerization activity (Armentero et al., 1994). The Nterminal 1/3 of the DNA-binding and dimerization domain contains a highly basic alphahelix. This helix consists of Lysine and arginine residues spaced at seven amino acid
intervals (Meisterernst et al., 1989). The C-terminal 2/3 of the DNA-binding and
dimerization domain contains four cysteine residues that are conserved between all NFI
DNA-binding domains. Three of these cysteines (Cys 104, 120, and 163 in human NFI-C)
are required for DNA-binding (Novak et al., 1992). The fourth cysteine (Cys 157) is
important for protection to oxidative damage, but is not needed for DNA-binding activity
(Bandyopadhyay et al., 1998).
The N-terminal domain is responsible for the DNA-binding and replication
activities of NFI proteins. On the other hand, the C-terminal domain of NFI proteins
regulates gene expression. Alternative splicing generates many variants of the C-terminal
domains; however, cloning and characterization of NFI-C transcripts show that residues
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399-499 are required for maximal transcriptional activity. This region is rich in proline
residues and when linked to DNA-binding domains can induce a five-to-ten fold increase
in transcription (Mermoid et al., 1989). Apart from its transcriptional activation, the Cterminal domain also includes a repression domain that inhibits transcription from many
promoters, including GLUT4 genes (Adams, et al., 1995). Although the exact mechanism
of repression is not known, direct competition with transactivators for binding has been
shown (Nehls et al., 1991, 1992).
During embryogenesis of mammals, the NFI genes are expressed in overlapping
patterns. NFI-A, -B and –X are highly expressed in the neocortex (Chaudhry et al., 1997).
As a result, knockout of Nfia and Nfib genes in mice caused neuroanatomical defects,
including a 5-10 fold decrease in the expression of astrocyte markers including Glial
Fibrillary Acidic Protein (GFAP) (Shu et al., 2003, Steele-Perkins, 2005 and Neves, das L.,
1999). Additionally, Nfib deficient mice die due to defects in lung development along with
abnormal hippocampus and pons formation (Steele-Perkins et al., 2005). Nfic gene
knockout causes early postnatal tooth formation defects (Steele-Perkins et al., 2003). Nfix
gene knockout causes hydrocephalus and agenesis of the corpus collosum and leads to
postnatal lethality in most animals (Driller et al., 2007). These knockout phenotypes of
Nfia, Nfib, and Nfix indicate their roles in normal brain development. NFI-C and –X
regulate expression of astrocyte markers during differentiation of neural precursors in vitro
(Wilczynska, 2009). However, these transcription factors also play a role in abnormal
brain physiology, such as gliogenesis (Deneen et al., 2006).
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Recently, our lab has cloned and analyzed a novel splice variant of the nfix gene,
NFI-X3. This variant contains a unique transcriptional activation (TA) domain
completely conserved in primates. Compared to NFI-X1, the overexpression of NFI-X3
more potently activates NFI reporters, including GFAP reporter, in astrocytes and glioma
cells. NFI-X3 expression is upregulated during the differentiation of neural progenitors to
astrocytes and precedes the expression of astrocyte marker, GFAP and Secreted Protein
Acidic Rich Cystein Like-1. The overexpression of NFI-X3 upregulates the expression of
these marker genes in astrocytes and glioma cells. The TA domain of NFI-X3 activates
GFAP expression by causing changes in the architecture of the +1 nucleosome that lead to
the increased recruitment of RNA polymerase II (Singh et al., 2011). Additionally, our lab
identified YKL-40 as a target gene of NFI-X3 in astrocytes and glioma cells that controls
their migration. YKL-40 expression is activated during mouse brain development and also
during the differentiation of neural progenitors into astrocytes in vitro. In primary
astrocytes, YKL-40 expression is also controlled by STAT3. The knock-down of NFI-X
and STAT3 significantly reduced YKL-40 expression in astrocytes, while overexpression
of NFI-X3 induced YKL-40 expression in glioma cells. In addition, we have found that
STAT3 and NFI-X3 activate YKL-40 expression via their binding site located in the YKL40 proximal promoter (Singh et al., 2011). Moreover, we have found that NFI-X and
STAT3 physically interact and it is possible that this complex may regulate YKL-40
expression.
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Hypothesis
STAT 3 and NFI-X3 control GFAP expression both in astrocytes and GBM cells.
Both of these transcription factors bind to their corresponding regulatory elements on the
enhancer region and cause the eviction of nucleosome of the GFAP promoter and induce
its expression (Singh et al., 2011). However, how these transcription factors regulate YKL40 expression is not known. Our lab showed that a YKL-40 reporter gene lacking four
NFI elements is fully activated by Oncostatin M, whereas the deletion of the proximal
STAT element (-78 to -69) significantly reduces reporter activity. Furthermore, NFI-X3
and STAT3 weakly bind to their juxtaposed elements in the YKL-40 promoter in vitro and
STAT3 co-immunoprecipitates with NFI-X3 from U373 cells (Singh et al., 2011). Thus,
we hypothesize that STAT3 may recruit NFI-X3 to the YKL-40 promoter. In fact, we
suspect that there is a direct interaction between STAT3 with NFI-X3 that is needed for the
regulation of YKL-40 expression. Therefore, we hypothesize that this complex regulates a
subset of genes, as is true for the NF-κB/STAT3 complex (Yang J. et al., 2007 and Yu et
al., 2002). The aim of this thesis is to identify the specific regions in NFI-X3 that are
required for its interaction with STAT3 and show that the NFI-X3/ STAT3 complex
regulates a subset of genes, including YKL-40.
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Materials and Methods
Cell culture and reagents: Human glioblastoma U373-MG cells and human embryonic
kidney HEK293 cells were provided by American Type Culture Collection (Rockville,
MD). These cells were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal calf serum, antibiotics, and non-essential amino acids.
Plasmids and site-directed mutagenesis: pSTAT3-V5 and vector expressing full-length
NFI-X3FLAG was obtained from Singh et al., (2011). The following deletions and point
mutations of NFI-X3FLAG were made using QuikChange® II Site-Directed Mutagenesis
Kit (Stratagene, Cedar Creek, TX) following their protocol. The above vector was used as
a template and primers were ordered from Eurofins MGE Operon, Huntsvillle, AL. The
forward 5’-CACCGGACAGAGGTCCGGAACCGATTACAAGGACGACG- 3’ and the
reverse 5’-GGTTCCGGACCTCTGTCCGGTGGCCTGG-3’ primers were used to delete
84 amino acids from the C-terminus of NFI-X3FLAG (NFI-X3FLAG-del 1). Plasmid
containing deletion was analyzed with AccIII. The forward, 5’- TGTGGATGCAAGGTC
CGGAACCGATTACAAGGACGACG-3’ and the reverse, 5’-GGTTCCGGACCTTGCA
TCCACATCGTTGG-3’ primers were used to delete 184 amino acids from the C-terminus
(NFI-X3FLAG-del 2). Plasmid containing this deletion was analyzed with BstXI. The
forward, 5’- TTTTGTGACTAGGTCCGGAACCGATTACAAGGACGACG-3’ and the
reverse, 5’- GGTTCCGGACCTAGTCACAAAACAGTCCTGG-3’ primers were used to
delete 284 amino acids from the C-terminus (NFI-X3FLAG-del 3). Plasmid containing
this deletion was analyzed with AccIII. The NFI-X3FLAG N-terminus α-helix deletion
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(NFI-X3FLAG-NT

del)

was

made

TCGCCATGGATGAGTTCCGCGAGGACTTCG-3’

using

the

and

TCGCGGAACTCATCCATGGCGAAGCTTGAATTC-3’

the

primers.

forward,

5’-

reverse,

5’-

The

plasmid

containing this deletion was analyzed with Hind III. The NFI- X3FLAG C148L, C154L
(NFI-X3FLAG-C148L, C154L) point mutations were made by using the forward, 5’CTCAGCTGTCGAACCCCGGCCTGCTCGTCCAGCCACATCACATTG-3’

and

the

reverse, 5’-TGGACGAGCAGGCCGGGGTTCGACAGCTGAGGCGACTTGTAGAGC 3’ primers. The plasmid containing these point mutations was analyzed with PvuII.
Transient Co-transfections: HEK293 cells were transiently transfected in 6 well clusters
using Lipofectamine LTX and PLUS Reagent (Invitrogen, Carlsbad, CA) using the
supplier’s protocol. On day 1, cells were transfected with 1 µg of NFI-X3FL, NFI-X3FLdel 1, NFI-X3FL- del 2, NFI-X3FL- del 3, NFI-X3FL-NT del and NFI-X3FL- C148L,
C154L mutation. On day 2, cells were transfected with 1 µg of pSTAT3-V5. Two days
after the intial transfection, cells were harvested, protein extracts were prepared, and
protein concentration was determined by the BCA method (Sigma Chemical Co., St.
Louis, MO).
Stabe Transfections: Stable clones were generated in U373 cells by using 4 µg of NFIX3FL- C148L, C154L plasmid and 0.2 µg of a second plasmid containing either zeocine or
hygromycin resistance gene. Cells were transfected in 10 cm dishes and clones were
selected in DMEM containing 100 µg/ml hygromycin and 300 µg/ml zeocine.
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Western blotting: Cells were lysed in 1 ml of IP buffer (10 mM Tris 7.4, 150 mM sodium
chloride, 1 mM EDTA, 0.5% NP-40, 1% Triton X-100, 1 mM sodium orthovanadate, and
protease inhibitor cocktail (Roche, Mannheim, Germany)). Samples were resolved using
SDS-PAGE and electroblotted onto nitrocellulose membrane (Schleicher & Schuell,
Keene, NH). The blots were incubated with an anti-FLAG antibody (0.3 µg/ml) or an antiV5 antibody (1.2 mg/ml) overnight at 4°C. The blots were washed extensively with a
solution containing 0.15M NaCl, 0.01M Tris pH 8.0, and 1% NP-40. The anti-FLAG
antibody was purchased from Sigma-Aldrich, St. Louis, MO. The anti-V5 antibody was
purchased from Invitrogen, Carlsbad, CA. Anti-mouse secondary antibody was used in
both cases and antigen-antibody complexes were visualized by enhanced
chemiluminescence using Immobilon Western blotting kit (Millipore, Temecula, CA).
Co-Immunoprecipitation: Protein lysates were prepared as described in western blotting
section. 20 µg/ml of FLAG beads (Sigma –Aldrich, St. Louis, MO) was added to tubes
containing 200-300 µg of protein lysates and 1 ml of IP buffer and incubated overnight at
4°C with rocking. Immunoprecipitates were washed three times with 1 ml of IP buffer and
once with 900 µl of 1X TBS (50 mM Tris pH 7.4, 150 mM NaCl). Complexes were eluted
using 15 µg of FLAG peptide and analyzed by SDS/PAGE (10% gels) followed by
western blot.
RNA isolation and quantitative PCR: Total cellular RNA was prepared using Trizol
(Invitrogen, Carlsbad, CA), following the manufacturer’s protocol. Subsequently, 1 µg of
total RNA was reverse-transcribed using the High Capacity cDNA Archive kit (Applied
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Biosystems, Foster City, CA). YKL-40, GFAP, and GAPDH mRNA levels were
measured using pre-mixed primer-probe sets, and TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, CA). The cDNAs were diluted 10-fold for the GFAP
and YKL-40 genes and 100-fold for GAPDH and amplified using the ABI 7900HT cycler.
Gene expression levels were normalized to GAPDH mRNA levels, and presented as a fold
induction with mean +/- standard deviation.
Nuclear Localization: HEK293 cells were transfected with 1 µg of NFI-X3FL, NFIX3FL- del 1, NFI-X3FL- del 2, NFI-X3FL- del 3, NFI-X3FL-NT del and NFI-X3FLC148L, C154L mutations using Lipofectamine LTX and PLUS Reagent (Invitrogen,
Carlsbad, CA) using the supplier’s protocol. Twenty-four hours after transfection, cells
were washed with non-sterile PBS three times, and fixed with 3% paraformaldehyde in
1ml for 30 minutes at room temperature. After PBS washing twice, cells were
permeabilized with 0.1% Triton-X for 20 minutes at room temperature. After PBS
washing twice, anti-FLAG (M2) (Sigma-Aldrich, Saint Louis, MO) antibody was prepared
in 5% ELISA grade BSA (1:100 dilution) and added to cells, which were then incubated at
4°C overnight under moist conditions. Next day, cells were washed with PBS twice and
Alexa Fluor® 488 anti-mouse IgG (Invitrogen, Carlsbad, CA) was used as a secondary
antibody (1:400 dilution), and cells incubated for thirty minutes in the dark. After washing
with PBS twice, Hoescht (50ng/ml) was added to the cells and incubated at room
temperature for 3 minutes. Cells were then washed with PBS twice. After cells were
mounted, they were visualized with Fluorescence microscopy and photographs were taken
using Nikon Eclipse E1000 camera.
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Results
Mutations of NFI-X3 domains.
In order to understand which domain of NFI-X3 is important for its interaction with
STAT3, deletion mutants were constructed using synthetic oligonucleotides (Figure 1 and
6). Three constructs were generated in which amino acids were deleted from the Cterminus: NFI-X3FL-del 1 lacked 84 amino acids (411-495), NFI-X3FL-del 2 lacked 184
amino acids (311-495) and NFI-X3FL-del 3 lacked 284 amino acids (211-495). To assess
the proper generation of these deletion mutants, digestions with restriction enzymes were
carried out and fragments visualized on 2% agarose gel with EtBr. In some cases, fulllength NFI-X3FL was digested as a control. The sizes of the fragments were predicted by
maps created using the ApE program. NFI-X3FL-del 1 was digested with AccIII. The
full- length plasmid showed a fragment of 6108 bases, whereas del 1 showed two
fragments, 696 and 5160 bases (Figure 2). NFI-X3FL-del 2 plasmid was digested with
BstXI. The full length plasmid showed two fragments, 5072 and 1040 bases, whereas del
2 showed fragments of 5074 and 489 bases (Figure 3). NFI-X3FL-del 3 was digested with
AccIII and showed two fragments of 5160 and 96 bases (Figure 4).

17
Figure 1: C-terminus deletions of NFI-X3FL. Synthetic oligonucleotides were used to
create three deletion mutants of NFI-X3FL. These mutants were created using the NFIX3FL as a template and using the QuikChange® Site-Directed Mutagenesis kit and
protocol. These mutants lack 84 amino acids (NFI-X3FL-del 1), 184 amino acids (NFIX3FL-del 2) and 284 amino acids (NFI-X3FL-del 3) from the C-terminus, as depicted
below. NFI-X3 consists of N-terminal α-helix, DNA-binding domain as well as four
conserved Cysteines within DNA-binding domain. On the C-terminus, NFI-X3 contains a
transcriptional activation (TA) domain.
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Figure 2: NFI-X3FL-del 1 plasmid digestion with AccIII. Synthetic oligonucleotides
were used to delete 84 amino acids from the C-terminus of NFI-X3FL using the full-length
NFI-X3FL as a template and following QuikChange® II Site-Directed Mutagensis Kit
protocol. Plasmid containing this deletion was purified and digested with AccII. Digestion
map showing the sizes of the predicted fragments of full-length and NFI-X3FL-del 1 were
created using the ApE program.
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Figure 3: NFI-X3FL-del 2 plasmid digestion with BstXI. Synthetic oligonucleotides
were used to delete 184 amino acids from the C-terminus of NFI-X3FL using the fulllength NFI-X3FL as a template and following QuikChange® II Site-Directed Mutagensis
Kit protocol. Plasmid containing this deletion was purified and digested with BstXI.
Digestion map showing the sizes of the predicted fragments of full-length and NFI-X3FLdel 2 were created using the ApE program.
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Figure 4: NFI-X3FL-del 3 plasmid digestion with AccIII. Synthetic oligonucleotides
were used to remove 284 amino acids from the C-terminus of NFI-X3FL using the fulllength NFI-X3FL as a template and following QuikChange® II Site-Directed Mutagensis
Kit protocol. Plasmid containing this deletion was purified and digested with AccIII.
Digestion map showing the sizes of the predicted fragments of NFI-X3FL-del 3 was
created using the ApE program.
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The N-terminus of NFI-X3 is sufficient for its interaction with STAT3.
In order to investigate if the C-terminus of NFI-X3 was needed for its interaction
with STAT3, an empty vector, full-length NFI-X3FL, NFI-X3FL-del1, NFI-X3FL-del 2,
and NFI-X3FL-del 3 were transiently transfected in HEK cells along with STAT3-V5.
Cells were lysed and ran on SDS-PAGE and expression of both STAT-V5 (92 kDa)
(Figure 5C) and NFI-X3FLAG (Figure 5B) was analyzed by Western Blot. Figure 5B
shows the expression of the NFI-X3FL constructs: full length NFI-X3FL (56 kDa), del 1
(45 kDa) , del 2 (36 kDa) and del 3 (26 kDa). The same lysates were used to perform CoImmunoprecipitation. Samples were then run on SDS-PAGE and result analyzed by
Western Blot (Figure 5A). Results show that with similar expression of both STAT3-V5
and NFI-X3FL, all three deletions are still able to interact with STAT3. However, the
interaction is weaker in cells containing the deletion mutants when compared to those
transfected with full- length NFI-X3.
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Figure 5: The N-terminus of NFI-X3 is sufficient for its interaction with STAT3.
HEK293 cells were co-transfected with 1µg of STAT3-V5 and 1 µg of empty vector, fulllength NFI-X3 or NFI-X3 containing either del 1, del 2 or del 3. 20 µg of proteins from
SDS-PAGE Then lysates using FLAG beads and STAT3-V5 was detected by western
blotting using anti-V5 antibodies (A). The expression of STAT3-V5 (C), NFI-X3FL and
the NFI-X3FL C-terminus deletion mutants (B) were determined in total lysates by
western blotting.
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The N-terminus alpha-helix is required for NFI-X3 and STAT3 interaction.
Co-Immunoprecipitation done with STAT3-V5 and C-terminus deletions of NFIX3FL showed that the N-terminus is sufficient for the interaction between STAT3 and
NFI-X3 (Figure 5A). Thus, the N-terminal alpha-helix was deleted (Figure 6). This
deletion mutant, NFI-X3FL-NT del, was made by deleting the N-terminal alpha helix
(Figure 6). Plasmid containing this deletion was digested with HindIII and showed
fragments of 4729 and 1161 bases (Figure 7). HEK293 cells were then co-transfected with
1 µg of NFI-X3FL-NT del and 1 µg of STAT3-V5 plasmids. . Cells transfected with
pFLAG5A was used as a negative control and cells transfected with NFI-X3FL served as a
positive control. After cells were lysed, they were run on SDS-PAGE and expression of
both plasmids was checked via Western Blot analysis. Indeed, these cells do express both
STAT3-V5 (92 kDa) (Figure 8C) and NFI-X3FL-NT del (46 kDa) (Figure 8B). Then, CoIP was performed and samples ran on SDS-PAGE and analyzed by Western Blot (Figure
8A). The results show that NFI-X3FL-NT del does not interact with STAT3. Hence, the
alpha-helix is required for the interaction of NFI-X3 with STAT3.
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Figure 6: NFI-X3FL-NT deletion. Synthetic oligonucleotides were used to create a
deletion mutant of NFI-X3FL. This mutant was created using the NFI-X3FL as a template
and using the QuikChange® Site-Directed Mutagenesis kit and protocol. In this mutant,
the α-helical domain is deleted, as depicted below. NFI-X3 consists of N-terminal α-helix,
DNA-binding domain as well as four conserved Cysteines within DNA-binding domain.
On the C-terminus, NFI-X3 contains a transcriptional activation (TA) domain.
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Figure 7: NFI-X3FL-NT del plasmid digestion with HindIII. Synthetic oligonucleotides
were used to delete the alpha-helical domain of NFI-X3FL using the full length NFI-X3FL
as a template and following QuikChange® II Site-Directed Mutagensis Kit protocol.
Plasmid containing this deletion was purified and digested with HindIII. Digestion map
showing the sizes of the predicted fragments of NT del containing NFI-X3FL was created
using the ApE program.
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Figure 8: The α-helical domain of NFI-X3 is required for its interaction with STAT3.
NFI-containing complexes were immunoprecipitated from HEK293 cells co-transfected
with 1 µg of both STAT3 and empty vector, full-length NFI-X3 or NFI-X3 containing NT
del using FLAG beads and STAT3-V5 was detected by western blotting using anti-V5
antibodies (A). The expression of STAT3-V5 (C), NFI-X3FL and the NFI-X3FL NT
deletion mutants (B) were determined in total lysates by western blotting.
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NFI-X3 forms a complex with STAT3 and regulates YKL-40 expression via direct
binding.
Moreover, a construct containing point mutations of two conserved cysteine
residues was made to assess whether NFI-X3 directly binds to the YKL-40 promoter to
induce its expression in GBMs (Figure 9). This plasmid, NFI-X3FL-C148L, C154L
mutation was digested with PvuII into four fragments, 2515, 1858, 1297 and 445 bases
(Figure 10). U373 stable cells were created by co-transfecting the cells with 4 µg of NFIX3FL- C148L, C154L mutation plasmid and 0.2 µg of a second plasmid containing either
zeocine or hygromycin resistance gene. Cells were then selected in DMEM containing 100
µg/ml hygromycin and 300 µg/ml zeocine. Cells were then lysed and run on SDS-PAGE
and analyzed by Western Blot for their expression of NFI-X3FL –C148L, C154L mutation
(56 kDa) (Results not shown). Moreover, RNA was isolated from these cells using TRizol
protocol (see materials and methods) and qPCR was performed to assess the expression of
YKL-40 and GFAP (Figure 11). The expression of both GFAP and YKL-40 was
significantly reduced in cells containing mutations in the DNA binding domain of NFI-X3
compared to cells that contained full-length NFI-X3 (Figure 11).
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Figure 9: NFI-X3FL-C148L, C154L point mutations. Synthetic oligonucleotides were
used to create a mutant of NFI-X3FL to abolish its DNA-binding ability. This mutant was
created using the NFI-X3FL as a template and using the QuikChange® Site-Directed
Mutagenesis kit and protocol. On the C-terminus, NFI-X3 contains a transcriptional
activation (TA) domain. On the N-terminus, NFI-X3 contains an α-helix, DNA-binding
domain as well as four conserved Cysteines within DNA-binding domain. Two of these
conserved cysteines (C148 and C154) within the DNA binding domain were mutated to
leucines, as depicted below.
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Figure 10: NFI-X3FL-C148L, C154L plasmid digestion with PvuII. Synthetic
oligonucleotides were used to mutate C148 and C154 of NFI-X3FL to leucines using the
full length NFI-X3FL as a template and following QuikChange® II Site-Directed
Mutagensis Kit protocol. Plasmid containing these point mutations was purified and
digested with PvuII. Digestion map showing the sizes of the predicted fragments after
digestion with PvuII was created using the ApE program.
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Figure 11: The DNA-binding domain of NFI-X3 is required to induce YKL-40
expression. Pools of U373 stable clones transfected with plasmids expressing either fulllength NFI-X3 or NFI-X3-C148L, C154L mutant or empty vector were cultured as
described in materials and methods. RNA was isolated from these cells and reverse
transcribed, and the expression of GFAP (A) and YKL-40 (B) was analyzed by qPCR.
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All NFI-X3FL constructs can translocate to the nucleus.
Staining was done to assess the ability of our NFI-X3FL deletion constructs to
translocate to the nucleus. HEK cells were transfected with 1 µg of pFLAG5A vector,
NFI-X3FL, NFI-X3FL-del 1, NFI-X3FL-del 2, NFI-X3FL-del 3, NFI-X3FL-NT del and
NFI-X3FL-C148L, C154L mutation. Twenty-four hours after transfection, cells were
washed and fixed onto cover slips and incubated overnight with anti-FLAG antibody
(1:100 dilutions). The next day, cells were washed and incubated with Alexa Fluor® 488
anti-mouse IgG antibody (1:400 dilutions) for thirty minutes in the dark. The cells were
then washed and incubated with Hoescht (50ng/ml) for 3 minutes, washed, and mounted
onto slides and pictures taken. Cells that contain FLAG epitope are green and the nuclei
are stained blue. Cells transfected with pFLAG5A was used as a negative control and cells
transfected with NFI-X3FL served as a positive control. Figure 12 shows that NFI-X3FLdel 1 was mainly in the nucleus, while NFI-X3FL-del 2 and NFI-X3FL-del 3 were both
cytoplamic and nuclear. However, NFI-X3FL-del 2 was located mainly in the cytoplasm.
NFI-X3FL-NT del was located both in the cytoplasm and nucleus, whereas NFI-X3FLC148L, C154L mutation was mostly located in the nucleus.
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Figure 12: All of the NFI-X3FL constructs can localize to the nucleus. Plasmids
containing either full length NFI-X3FL or NFI-X3FL deletion mutants or empty vector
were transfected into HEK293 cells and stained with Alexa Fluoro 488 anti-mouse IgG to
recognize the FLAG epitope and Hoescht (similar to DAPI) for nuclear staining and
visualized by Fluorescent Microscopy.
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Discussion
Malignant glioblastoma (GBM) are highly invasive and resistant to radiation and
other treatments. As a result, patients with GBMs have poor prognosis. Recent research
has shown that a secreted ECM protein, YKL-40, is highly expressed in GBMs and that its
high expression is associated with the GBMs’ resistance to radiation as well as its invasive
nature (Nigro et al., 2005 and Francescone et al., 2011). However, how this expression of
YKL-40 in GBMs is regulated is not known. Recently, Singh et al. (2011) showed that
YKL-40 is regulated by Nuclear Factor I-X3 (NFI-X3) and Signal Transducers and
Activator of Transcription 3 (STAT3), which can form a complex. Moreover, Singh et al.,
(2011) showed that the binding of both STAT3 and NFI-X3 is required for the expression
of the astrocyte marker, Green Fibrillary Acidic Protein (GFAP).
In this study, we set out to find the domains of NFI-X3 that are required for the
formation of this complex. First, deletions were made by removing 84, 184 and 284 amino
acids from the C-terminus of NFI-X3. Co-Immunoprecipitation experiments carried out
with these deletions show that STAT3 and NFI-X3 do indeed form a complex and that, the
N-terminus of NFI-X3 is sufficient for its interaction with STAT3 (Figure 5). However, the
interaction is diminished in these deletions, suggesting that the C-terminus may stabilize
this interaction. The C-terminal transcriptional activation (TA) domain is rich in prolines,
which play an important role in regulating protein-protein interactions. Thus, these
prolines might play a role in stabilizing the interaction between STAT3 and NFI-X3. To
further elucidate which N-terminus domains are required, the alpha-helical domain of NFI-
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X3 was deleted. Co-Immunoprecipitation with this deletion and STAT3 shows that the
alpha-helical domain is indispensable for this interaction (Figure 8). NFI genes can
undergo alternative splicing, affecting mostly their C-terminus, to generate transcription
factors with diverse functions. Grunder et al., 2003 showed that splice variants of NFI-A,
NFI-B and NFI-C are active transcription factors. It would be of great interest to assess
whether these NFI-X3 C-terminus deletion mutants are active and if they regulate genes
that are distinct from those controlled by NFI-X3.
We also show that all of the NFI-X3 constructs that we created are capable of
translocating to the nucleus (Figure 12). NFI proteins contain two nuclear localization
signals (NLS) located on exon 2 and exons 3-6. The NLS located on exon 2 (NLS1) is
composed of 24 amino acids (aa 36-50), RKRKYFKKHEKRMSK while the NLS located
on exon 3-6 (NLS2) is composed of 34 amino acids (aa 251-284),
RRSITSPPSTSTTKRPK (Imagawag et al. 2008). Complete nuclear localization requires
both signals, although, one signal is sufficient for some localization. NFI-X3FL-del 1,
NFI-X3FL-del 2, and NFI-X3FL C148L, C154L mutation constructs contain both nuclear
localization signals. However, NFI-X3FL-del 3 contains only NLS1, whereas NFI-X3FLNT del contains only NLS2. As a result, these constructs do not localize to the nucleus as
well as those that contains both NLS signals. Most importantly, the ability of these
constructs to localize to the nucleus does not affect their capacity to interact with STAT3
as it shuttles between the cytoplasm and nucleus (Meyer and Vinkemeier, 2004) resulting
in a steady state subcellular distribution that results from continuous nuclear import and
export (Pranada et al., 2004).
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We also wanted to assess whether NFI-X3 and STAT3 regulate YKL-40 expression
by binding directly to the gene, like that shown for GFAP expression.

In order to test

this, NFI-X3FL containing point mutations within the DNA binding domain was created
(Figure 9). Novak et al., (1992) showed that three (C104, 120 and 163) of the four
conserved cysteine residues within the DNA binding domain of NFI-C are required for
DNA binding. In our construct, Cys 148 and 154, corresponding to Cys 104 and 120, were
mutated to leucines. Stably transfected U373 cells containing this construct show that the
DNA binding domain of NFI-X3 is required to induce YKL-40 expression (Figure 11).
This suggests that NFI-X3 binds directly to the YKL-40 promoter. Indeed, Singh et al.,
(2011) showed that NFI-X3 binds to NFI elements in glioma cells and it may be recruited
together with STAT3. Investigation of the molecular mechanism of NFI-mediated gene
activation has led to discoveries that NFIs bind to their specific binding elements, but can
also interact with histone H3 (Muller and Mermod, 2000) and remodeling complexes,
including Brg1 (Zhao et al., 2005). It will be important to determine if chromatin
remodeling is a mechanism regulating NFI-dependent transcription of YKL-40. Singh et
al., (2011) also showed that both NFI-X3 and STAT3 weakly bind to the adjacently
located NFI and STAT elements on the YKL-40 promoter. Therefore, STAT3 may
stabilize the weak binding of NFI-X3 and also recruit NFI-X3 to the YKL-40 promoter.
Further investigation is required to determine the involvement of other transcription factors
that may form complexes with STAT3 and NFI-X3. It is also important to determine if
these transcription factors can form an enhanceosome with cooperative binding, like that of
the IFN-β enhanceosome (Escalante et al., 2007). More exploration is also needed to
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determine the subset of genes that are regulated by the STAT3 and NFI-X3 complex. In
summary, we propose that NFI-X3 and STAT3 form a complex via the alpha-helical
domain of NFI-X3 and this complex induces YKL-40 expression by stabilizing the weak
binding of NFI-X3 to the YKL-40 promoter.
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